CD109 and asthma: CD109 deficiency reduces airway hyperreactivity and eosinophilic inflammation, with decreased levels of Th2 cytokines in mice.[40] CD109 plays a critical role in the pathogenesis of asthma, making it a potential therapeutic target for the disease.